PPA
KRON

Parametric Portfolio Associates’s Kronos Bio KRON Stock Holding History

Parametric Portfolio Associates’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$131K Buy
18,076
+7,849
+77% +$66.9K ﹤0.01% 3521
2021
Q4 		$139K Sell
10,227
-6,951
-40% -$109K ﹤0.01% 3500
2021
Q3 		$360K Buy
+17,178
New +$369K ﹤0.01% 3228

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Parametric Portfolio Associates's KRON Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Kronos Bio (KRON) stake by 77% in Q1 2022, buying an estimated $66.9K and bringing the position to 18,076 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #3521.

Parametric Portfolio Associates first reported a position in KRON in Q3 2021 and has held it in 3 quarters since. The position peaked at $360K in Q3 2021. 96 funds tracked by Wall St. Rank hold KRON as of Q1 2022.

  • Parametric Portfolio Associates held 18,076 shares of Kronos Bio worth $131K as of Q1 2022.
  • Parametric Portfolio Associates bought 7,849 Kronos Bio shares in Q1 2022, an estimated $66.9K.
  • Kronos Bio made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3521 holding.
  • Parametric Portfolio Associates first reported a position in Kronos Bio in Q3 2021 and has held it in 3 quarters since.
  • Parametric Portfolio Associates's Kronos Bio position peaked at $360K in Q3 2021.
  • 96 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.